Cite

HARVARD Citation

    Shafi, S. et al. (2023). HER2 Gene Protein Assay: A Robust Tool for Evaluating HER2 Status and Intratumoral Heterogeneity in Endometrial Cancers. American journal of clinical pathology. 159 (5), pp. 464-473. [Online]. 
  
Back to record